SCHEMBL21753593

SCHEMBL21753593

Cc1cc(OCCCC(C)(C)C(N)=O)c(C)cc1Br

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 5/20 0.50
TSHR P16473 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CYP2C8 P10632 2/20 0.50
CYP2C9 P11712 2/20 0.50
TTR P02766 1/20 0.50
CYP1A2 P05177 1/20 0.50
CHRM1 P11229 1/20 0.50
ADRA1A P35348 1/20 0.50
PPARG P37231 1/20 0.50
HTR2B P41595 1/20 0.50
SLCO1B3 Q9NPD5 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CISD1 Q9NZ45 1/20 0.50
SLCO1B1 Q9Y6L6 1/20 0.50
GALR3 O60755 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
NR1H4 Q96RI1 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21753575 0.89 PPARA (0.64) PPARATSHRSMN1; SMN2CYP2C8CYP2C9
SCHEMBL21753561 0.84 PPARA (0.59) PPARATSHRSMN1; SMN2CYP2C8CYP2C9
SCHEMBL21753558 0.81 PPARA (0.55) PPARATSHRSMN1; SMN2CYP2C8CYP2C9
SCHEMBL21757415 0.81 PPARA (0.43) PPARATSHRSMN1; SMN2CYP2C8CYP2C9
SCHEMBL21753555 0.80 PPARA (0.47) PPARATSHRSMN1; SMN2CYP2C8CYP2C9
SCHEMBL11090319 0.79 PPARA (0.75) PPARATSHRSMN1; SMN2CYP2C8CYP2C9
SCHEMBL21757427 0.77 PPARA (0.40) PPARATSHRSMN1; SMN2CYP2C8CYP2C9
SCHEMBL9463720 0.77 PPARA (0.64) PPARATSHRSMN1; SMN2CYP2C8CYP2C9
SCHEMBL21753557 0.77 PPARA (0.56) PPARATSHRSMN1; SMN2CYP2C8CYP2C9
SCHEMBL21753578 0.77 PPARA (0.56) PPARATSHRSMN1; SMN2CYP2C8CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313522-A1 PHENOXY CARBOXYLIC ACID COMPOUNDS AND MEDICAL USES THEREOF QINGDAO RISING BIOTECHNOLOGY CO., LTD (CN) 2025-10-09 US disclosed
US-12365643-B2 Phenoxy carboxylic acid compounds and medical uses thereof QINGDAO RISING BIOTECHNOLOGY CO., LTD (CN) 2025-07-22 US disclosed
CN-110857268-B Phenoxy acid compound and medical application thereof 青岛睿森生物科技有限公司 2022-10-04 CN disclosed
US-20220119333-A1 PHENOXY ACID COMPOUNDS AND MEDICAL USES THEREOF QINGDAO WHOLESOMTECH CO., LTD. (CN) 2022-04-21 US disclosed
EP-3842410-A1 FIBRIC ACID COMPOUND AND MEDICAL USE THEREOF Beijing Wholesomeyird Sci & Tech Co., Ltd. (CN) 2021-06-30 EP disclosed
CN-110857268-A Phenoxy acid compound and medical application thereof 北京厚燊药德科技有限责任公司 2020-03-03 CN disclosed
WO-2020038464-A1 FIBRIC ACID COMPOUND AND MEDICAL USE THEREOF 北京厚燊药德科技有限责任公司 2020-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119333-A1 PHENOXY ACID COMPOUNDS AND MEDICAL USES THEREOF PYGL, SLC10A1, GYS2 PPARA 10/4885TSHR 2406/4885SMN1; SMN2 3774/4885
US-12365643-B2 Phenoxy carboxylic acid compounds and medical uses thereof PYGL, SLC10A1, GYS2 PPARA 9/4885TSHR 2525/4885SMN1; SMN2 3979/4885
US-20250313522-A1 PHENOXY CARBOXYLIC ACID COMPOUNDS AND MEDICAL USES THEREOF PYGL, SLC10A1, GYS2 PPARA 9/4885TSHR 2525/4885SMN1; SMN2 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.